| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027347 |
| Receipt No. | R000031293 |
| Scientific Title | The clinical evaluation of the frail skin improvement in elderly person effected by the Nutritional Supplement Drink(Containing Collagen Peptide, Vitamins, and Minerals) intake. |
| Date of disclosure of the study information | 2017/05/15 |
| Last modified on | 2020/05/18 (Ver. 4) |
| Basic information | ||
| Public title | The clinical evaluation of the frail skin improvement in elderly person effected by the Nutritional Supplement Drink(Containing Collagen Peptide, Vitamins, and Minerals) intake.
|
|
| Acronym | The clinical evaluation of the frail skin improvement in elderly person effected by the Nutritional Supplement Drink intake. | |
| Scientific Title | The clinical evaluation of the frail skin improvement in elderly person effected by the Nutritional Supplement Drink(Containing Collagen Peptide, Vitamins, and Minerals) intake.
|
|
| Scientific Title:Acronym | The clinical evaluation of the frail skin improvement in elderly person effected by the Nutritional Supplement Drink intake. | |
| Region |
|
|
| Condition | ||
| Condition | Skin function decline
|
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The study will be performed for the purpose of assessing the contribution of nutritional supplement drink containing the increased amount of micronutrients and collagen peptide to improve the condition of frail skin. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Skin elasticity |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Continue no treatment for 56 days | |
| Interventions/Control_2 | Take one bottle of the nutritional supplement drink every day for 56 days | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | -Inpatient who has taken 80% or more of supplied meals before the start of the study | |||
| Key exclusion criteria | -Patient who has a skin disease that needs treatment or is immeasurable in the evaluation site
-Patient with chronic renal disease -Patient using corticosteroids or receiving special skin care -Patient who has developed aspiration pneumonia within one month -Patient disqualified from participating in the Study by the doctor |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Minamino Hospital | ||||||
| Division name | medical quality management department | ||||||
| Zip code | |||||||
| Address | 5-30-3 minamino, Hachioji City, Tokyo | ||||||
| TEL | 042-632-8118 | ||||||
| nomoto@eisei.or.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Minamino Hospital | ||||||
| Division name | medical quality management department | ||||||
| Zip code | |||||||
| Address | 5-30-3 minamino, Hachioji City, Tokyo | ||||||
| TEL | 042-632-8118 | ||||||
| Homepage URL | |||||||
| nomoto@eisei.or.jp | |||||||
| Sponsor | |
| Institute | Minamino Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | NUTRI Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000031293 |